Simplex Trading’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-28,306
| Closed | -$269K | – | 8910 |
|
|
2020
Q2 | $216K | Buy |
+28,306
| New | +$217K | ﹤0.01% | 3915 |
|
|
2019
Q3 | – | Sell |
-12,760
| Closed | -$134K | – | 8203 |
|
|
2019
Q2 | $127K | Buy |
12,760
+5,360
| +72% | +$57.8K | ﹤0.01% | 3945 |
|
|
2019
Q1 | $95K | Buy |
+7,400
| New | +$110K | ﹤0.01% | 4387 |
|
|
2018
Q2 | – | Sell |
-564
| Closed | -$12.5K | – | 8138 |
|
|
2018
Q1 | $11K | Sell |
564
-60,333
| -99% | -$1.02M | ﹤0.01% | 3985 |
|
|
2017
Q4 | $806K | Buy |
+60,897
| New | +$918K | 0.03% | 487 |
|
|
2016
Q4 | – | Sell |
-17,181
| Closed | -$513K | – | 6828 |
|
|
2016
Q3 | $421K | Sell |
17,181
-2,594
| -13% | -$64.8K | 0.03% | 598 |
|
|
2016
Q2 | $473K | Buy |
19,775
+9,057
| +85% | +$208K | 0.03% | 542 |
|
|
2016
Q1 | $250K | Buy |
10,718
+4,839
| +82% | +$115K | 0.02% | 750 |
|
|
2015
Q4 | $177K | Sell |
5,879
-40
| -0.7% | -$1.29K | 0.01% | 961 |
|
|
2015
Q3 | $235K | Buy |
5,919
+1,252
| +27% | +$77.7K | 0.02% | 816 |
|
|
2015
Q2 | $322K | Buy |
+4,667
| New | +$294K | 0.03% | 547 |
|
Simplex Trading's AMAG Position: Q3 2020 in Review
Simplex Trading sold out of AMAG Pharmaceuticals (AMAG) in Q3 2020, closing a stake of 28,306 shares — an estimated $269K sold.
Simplex Trading first reported a position in AMAG in Q2 2015 and held it in 11 quarters. The position peaked at $806K in Q4 2017. 113 funds tracked by Wall St. Rank hold AMAG as of Q3 2020.
- Simplex Trading reported no remaining AMAG Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
- Simplex Trading sold 28,306 AMAG Pharmaceuticals shares in Q3 2020, an estimated $269K.
- Simplex Trading first reported a position in AMAG Pharmaceuticals in Q2 2015 and held it in 11 quarters.
- Simplex Trading's AMAG Pharmaceuticals position peaked at $806K in Q4 2017.
- 113 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2020.
Based on Simplex Trading's 13F filing for Q3 2020, filed 14 Oct 2020.